Compare Davita Inc (DVA) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs SoundHound AI Inc — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while SoundHound AI Inc trades at $7.46 (market cap $3.25B). The key difference: Davita Inc is far larger — about 3.6× SoundHound AI Inc's market cap, and Davita Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| DVA | SOUN | |
|---|---|---|
Market Cap | $11.72B | $3.25B |
Sector | Health | Technology |
52-Week High | $240.96 | $21.40 |
52-Week Low | $103.87 | $5.70 |
Enterprise Value | $24.44B | $3.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
SoundHound AI (SOUN) trades at $8.02, up 13.28% today, showing strong momentum after beating Q2 2026 earnings expectations. The stock maintains a bullish technical signal with support at $7 and resistance at $9. Revenue grew 45% last quarter to $61.9M, though the company remains unprofitable with a -67.45% net margin. Analyst consensus is strongly bullish with 75% buy ratings and an $8.50 price target.
SOUN offers growth potential through its OASYS platform expansion and enterprise adoption, but faces significant execution risks from persistent losses, cash burn, and premium valuation. The stock's near-term trajectory depends on continued revenue acceleration and path to profitability. High valuation multiples and negative cash flow present challenges despite strong analyst support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
